Cytosorbents (CTSO) Current Assets (2010 - 2026)
Cytosorbents' (CTSO) quarterly Current Assets came in at $17.8 million in Q1 2026, down 30.13% YoY from $25.4 million in Q1 2025, and down 13.94% on a QoQ basis from $20.6 million in Q4 2025.
Cytosorbents (CTSO) Current Assets (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Current Assets data on file, last reported at $17.8 million in Q1 2026.
- Quarterly Current Assets fell 30.13% year-over-year to $17.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.8 million (down 30.13% YoY) and the FY2025 annual result came in at $20.6 million, down 4.49% from the prior year.
- Current Assets eased to $17.8 million in Q1 2026, from $20.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $55.9 million in Q1 2022 to a low of $16.6 million in Q3 2024.
- A 5-year average of $26.4 million and a median of $23.0 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets plunged 55.49% — and 2025, when it grew 28.41%.
- Tracing CTSO's Current Assets over 5 years: stood at $33.8 million in 2022, then retreated by 24.77% to $25.4 million in 2023, then retreated by 14.94% to $21.6 million in 2024, then decreased by 4.49% to $20.6 million in 2025, then retreated by 13.94% to $17.8 million in 2026.
- The last three Current Assets figures came in at $17.8 million (Q1 2026), $20.6 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 15.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.74 Mn |
| Mar 31, 2026 | 17.76 Mn |
| Dec 31, 2025 | 20.63 Mn |
| Sep 30, 2025 | 21.31 Mn |
| Jun 30, 2025 | 22.99 Mn |
| Mar 31, 2025 | 25.41 Mn |
| Dec 31, 2024 | 21.60 Mn |
| Sep 30, 2024 | 16.60 Mn |
| Jun 30, 2024 | 21.96 Mn |
| Mar 31, 2024 | 19.99 Mn |
| Dec 31, 2023 | 25.40 Mn |
| Sep 30, 2023 | 19.26 Mn |
| Jun 30, 2023 | 23.64 Mn |
| Mar 31, 2023 | 28.16 Mn |
| Dec 31, 2022 | 33.76 Mn |
| Sep 30, 2022 | 32.38 Mn |
| Jun 30, 2022 | 41.65 Mn |
| Mar 31, 2022 | 55.85 Mn |
| Dec 31, 2021 | 64.30 Mn |
| Sep 30, 2021 | 72.75 Mn |